Function[change | change source]
In humans[change | change source]
Relaxin is produced in females. It rises to a peak about 14 days after ovulation, and then declines if the egg is not fertilised. During the first three months of pregnancy, levels rise and more relaxin is produced. Relaxin adjusts blood supply during pregnancy. It also relaxes pelvic ligaments. It softens the pubic symphysis (the ligaments joining the bottom of the pelvis).
In other animals[change | change source]
In animals, relaxin widens the pubic bone and facilitates labor. It also softens the cervix (cervical ripening), and relaxes the uterine musculature. Thus, for a long time, relaxin was looked at as a pregnancy hormone. However, its significance may reach much further. Relaxin affects collagen metabolism, inhibiting collagen synthesis and enhancing its breakdown.
References[change | change source]
- Bani D (1997). "Relaxin: a pleiotropic hormone.". General pharmacology 28 (1): 13–22. doi:10.1016/s0306-3623(96)00171-1. PMID 9112071.
- Conrad K.P. (2011). "Maternal vasodilation in pregnancy: the emerging role of relaxin". Am. J. Physiol. Regul. Integr. Comp. Physiol. 301 (2): R267–75. doi:10.1152/ajpregu.00156.2011. PMC 3154715. PMID 21613576.
- Weiss G (1989). "Relaxin in the male". Biol. Reprod. 40 (2): 197–200. doi:10.1095/biolreprod40.2.197. PMID 2497805. http://www.biolreprod.org/cgi/reprint/40/2/197.
- Mookerjee I. et al (2006). "Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease". Endocrinology 147 (2): 754–61. doi:10.1210/en.2005-1006. PMID 16254028.